Amyloid
Showing 1 - 25 of 1,651
High Frequency Imaging in Cerebral Amyloid Angiopathy
Recruiting
- Cerebral Amyloid Angiopathy
- MR Imaging
-
Bonn, Germany
- +2 more
Nov 7, 2023
Cerebral Amyloid Angiopathy Trial in Leiden (Minocycline, Placebo)
Recruiting
- Cerebral Amyloid Angiopathy
- Minocycline
- Placebo
-
Leiden, NetherlandsLeiden University Medical Center
Dec 26, 2022
Learn About Tafamidis in Transthyretin Amyloid Cardiomyopathy in
Not yet recruiting
- Transthyretin Amyloid Cardiomyopathy
- (no location specified)
Oct 11, 2023
Florbetaben for Imaging of Vascular Amyloid
Recruiting
- Acute Coronary Syndrome
- +3 more
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Oct 13, 2023
Cerebellar Superficial Siderosis in Cerebral Amyloid Angiopathy
Completed
- Cerebral Amyloid Angiopathy
- Siderosis
- None, pure observational study
-
Nîmes, FranceCHU de Nîmes
Dec 5, 2022
Systemic Amyloidosis Trial in Knoxville (Injection of peptide p5+14 radiolabeled with iodine-124 (124I-AT-01))
Active, not recruiting
- Systemic Amyloidosis
- Injection of peptide p5+14 radiolabeled with iodine-124 (124I-AT-01)
-
Knoxville, TennesseeUniversity of Tennessee Graduate School of Medicine
Jul 28, 2023
Wild-Type Transthyretin Amyloid Cardiomyopathy And Non-Amyloid
Not yet recruiting
- ATTR-CM
- Machine learning algorithm
-
New York, New YorkPfizer
Sep 1, 2023
Cerebral Amyloid Angiopathy Trial in Newport Beach, Pasadena (AMDX-2011P)
Not yet recruiting
- Cerebral Amyloid Angiopathy
-
Newport Beach, California
- +1 more
Jan 24, 2023
Medicare Anti-Aß mAb Coverage With Evidence Development Study
Recruiting
- Mild Alzheimer's Disease
- Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
- Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
-
Baltimore, MarylandCenters for Medicare and Medicaid Services
Sep 21, 2023
Periventricular White Matter Hyperintensities in Cerebral
Not yet recruiting
- Cerebral Amyloid Angiopathy
- Hypertensive Arteriopathy
- None, pure observational study
- (no location specified)
Aug 2, 2022
Amyloid Neuropathies, Transthyretin Amyloidosis Trial in Marseille (Electrophysiological biomarkers, MRI biomarkers)
Completed
- Amyloid Neuropathies
- Transthyretin Amyloidosis
- Electrophysiological biomarkers
- MRI biomarkers
-
Marseille, Paca, FranceAssistance Publique Des Hopitaux de Marseille
Oct 2, 2022
Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Heart Failure With Mid Range
Recruiting
- Heart Failure With Reduced Ejection Fraction
- +3 more
- Dapagliflozin 10mg Tab
- Placebo
-
Moscow, Russian FederationNational Medical Research Center for Cardiology, Ministry of Hea
Mar 20, 2023
Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer Disease
Recruiting
- Alzheimer Disease
-
Saint Louis, MissouriWashington University School of Medicine
Feb 7, 2023
Amyloid, Amyloid Cardiomyopathy Trial in Pisa (18F-florbetaben PET/CT)
Recruiting
- Amyloid
- Amyloid Cardiomyopathy
- 18F-florbetaben PET/CT
-
Pisa, ItalyFondazione Toscana Gabriele Monasterio
Sep 16, 2023
[18F]Florbetazine for Beta Amyloid PET Imaging in Alzheimer's
Recruiting
- Alzheimer's Disease
- [18F]Florbetazine ([18F]92)
- [11C]PIB
-
Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hop
Nov 19, 2023
Program to Identify Participants at High Risk for Amyloid
Not yet recruiting
- Alzheimer's Disease
- No Intervention
-
Lady Lake, Florida
- +1 more
Sep 12, 2023
Cerebral Amyloid Angiopathy, Small Vessel Cerebrovascular Disease, Cadasil Trial in Bern
Recruiting
- Cerebral Amyloid Angiopathy
- +3 more
-
Bern, SwitzerlandDepartment of Neurology, Inselspital Bern University Hospital
Feb 8, 2023
Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) Trial in Indianapolis (Eplontersen)
Recruiting
- Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
-
Indianapolis, IndianaIndiana University Health University Hospital
Jan 12, 2023
Pre-thrombolysis MRI Treated With Intravenous Thrombolysis
Recruiting
- Hemorrhage
- +2 more
- None, pure observational study
-
Nimes, FranceCHU de Nîmes
Dec 5, 2022
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
Not yet recruiting
- Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
- +2 more
-
Auckland, New Zealand
- +2 more
Jan 24, 2023
Glioblastoma Trial in Bayamon, San Juan (Amyvid, Intravenous Solution)
Not yet recruiting
- Glioblastoma
- Amyvid, Intravenous Solution
-
Bayamon, Puerto Rico
- +1 more
Apr 18, 2023
Samples and Clinical Data From Patients With Amyloid Diseases
Recruiting
- Multiple Myeloma
- clonality analysis
- +6 more
-
Boston, MassachusettsBoston University Cancer Research Center
Jan 28, 2023
Alzheimer Trial in Saint Louis (Lemborexant 25 mg, Placebo)
Recruiting
- Alzheimer Disease
- Lemborexant 25 mg
- Placebo
-
Saint Louis, MissouriWashington University School of Medicine
Feb 16, 2023
Alzheimer Trial in United States (Anti-amyloid Monoclonal Antibodies (mAbs), Standard of Care)
Not yet recruiting
- Alzheimer Disease
- Anti-amyloid Monoclonal Antibodies (mAbs)
- Standard of Care
-
Albany, Georgia
- +7 more
Aug 13, 2023
Vyndamax® Capsules for Treatment of Transthyretin Amyloid
Recruiting
- ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
- Vyndamax (tafamidis 61mg)
-
Seoul, Korea, Republic ofPfizer
Aug 16, 2022